SHS Capital Acquires Majority Stake in Ackermann Instrumente GmbH

SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH through its fund SHS VI. This move is aimed at forming a leading MedTech group by expanding core operations and engaging in strategic partnerships and acquisitions.

Ackermann, renowned for its high-quality surgical instruments, serves a global clientele, particularly in endoscopy, implantology, and general surgery. The company's vertically integrated production ensures quality and cost efficiency, making it a valuable partner in the medical field.

The acquisition facilitates the succession of the family business. Rolf Ackermann stays on as a minority shareholder while Peter Grassl continues as CEO to maintain growth. SHS intends to leverage Ackermann’s global sales network to realize synergies and expand within the MedTech sector.